GC formation in recipients given CD4-Stat3−/− TCD-BM was not completely absent, but the size and numbers of GCs were reduced by more than 50% (Fig. 7g) as compared to no-GVHD recipients given CD4-Stat3+/+ TCD-BM. This evidence concerns the gene STAT3 and graft versus host disease.